M&R Capital Management’s Gabelli Healthcare & Wellness Trust GRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $329 | Hold |
30
| – | – | ﹤0.01% | 565 |
|
|
2024
Q2 | $287 | Sell |
30
-16
| -35% | -$153 | ﹤0.01% | 532 |
|
|
2024
Q1 | $471 | Hold |
46
| – | – | ﹤0.01% | 534 |
|
|
2023
Q4 | $429 | Hold |
46
| – | – | ﹤0.01% | 621 |
|
|
2023
Q3 | $395 | Hold |
46
| – | – | ﹤0.01% | 605 |
|
|
2023
Q2 | $458 | Hold |
46
| – | – | ﹤0.01% | 600 |
|
|
2023
Q1 | $464 | Hold |
46
| – | – | ﹤0.01% | 591 |
|
|
2022
Q4 | $472 | Hold |
46
| – | – | ﹤0.01% | 584 |
|
|
2022
Q3 | $0 | Hold |
46
| – | – | ﹤0.01% | 436 |
|
|
2022
Q2 | $0 | Hold |
46
| – | – | ﹤0.01% | 435 |
|
|
2022
Q1 | $0 | Hold |
46
| – | – | ﹤0.01% | 435 |
|
|
2021
Q4 | $0 | Hold |
46
| – | – | ﹤0.01% | 416 |
|
|
2021
Q3 | $0 | Hold |
46
| – | – | ﹤0.01% | 417 |
|
|
2021
Q2 | $0 | Hold |
46
| – | – | ﹤0.01% | 423 |
|
|
2021
Q1 | $0 | Hold |
46
| – | – | ﹤0.01% | 419 |
|
|
2020
Q4 | $0 | Hold |
46
| – | – | ﹤0.01% | 443 |
|
|
2020
Q3 | $0 | Hold |
46
| – | – | ﹤0.01% | 461 |
|
|
2020
Q2 | $0 | Hold |
46
| – | – | ﹤0.01% | 470 |
|
|
2020
Q1 | $0 | Hold |
46
| – | – | ﹤0.01% | 476 |
|
|
2019
Q4 | $0 | Hold |
46
| – | – | ﹤0.01% | 490 |
|
|
2019
Q3 | $0 | Hold |
46
| – | – | ﹤0.01% | 496 |
|
|
2019
Q2 | $0 | Hold |
46
| – | – | ﹤0.01% | 499 |
|
|
2019
Q1 | $0 | Hold |
46
| – | – | ﹤0.01% | 506 |
|
|
2018
Q4 | $0 | Hold |
46
| – | – | ﹤0.01% | 515 |
|
|
2018
Q3 | $0 | Hold |
46
| – | – | ﹤0.01% | 534 |
|
|
2018
Q2 | $0 | Hold |
46
| – | – | ﹤0.01% | 521 |
|
|
2018
Q1 | $0 | Hold |
46
| – | – | ﹤0.01% | 533 |
|
|
2017
Q4 | $0 | Hold |
46
| – | – | ﹤0.01% | 544 |
|
|
2017
Q3 | $0 | Hold |
46
| – | – | ﹤0.01% | 550 |
|
|
2017
Q2 | $0 | Hold |
46
| – | – | ﹤0.01% | 552 |
|
|
2017
Q1 | $0 | Hold |
46
| – | – | ﹤0.01% | 559 |
|
|
2016
Q4 | $0 | Hold |
46
| – | – | ﹤0.01% | 561 |
|
|
2016
Q3 | $0 | Hold |
46
| – | – | ﹤0.01% | 547 |
|
|
2016
Q2 | $0 | Buy |
+46
| New | – | ﹤0.01% | 525 |
|